المؤلفون: Xiaoyun Li, Cathy Anne Pinto, Emilie Scherrer, Mizuho Kalabis, Xinyue Liu

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)

مصطلحات موضوعية: medicine.medical_specialty, Chemotherapy, Combination therapy, business.industry, medicine.medical_treatment, Medical record, Disease progression, Pembrolizumab, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, Stable Disease, Internal medicine, medicine, Nivolumab, business, Social Security Death Index

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67a08aa4a18c0690b927dab1976b7af3Test
https://doaj.org/article/1bfc61267f7a45059e87b4fee703575bTest

المؤلفون: Evan J. Lipson, Ragini R. Kudchadkar, Sunil Reddy, Tomoko Akaike, Thomas Olencki, William H. Sharfman, Philip Friedlander, Steven P. Fling, Mizuho Kalabis, Candice D. Church, Kari Kendra, Michi M. Shinohara, Adil Daud, Adam I. Riker, Harriet M. Kluger, Elad Sharon, Melissa Amber Burgess, Janis M. Taube, Paul Nghiem, Brent A. Hanks, Suzanne L. Topalian, Blanca Homet Moreno, Andrew S. Brohl, Brian C. Boulmay, Martin A. Cheever, Bob Salim, Erin Jensen, Shailender Bhatia, Nirasha Ramchurren

المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 4 (2021)
Journal for immunotherapy of cancer, vol 9, iss 4
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Skin Neoplasms, Time Factors, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Pembrolizumab, 0302 clinical medicine, Stable Disease, Cancer immunotherapy, Monoclonal, 80 and over, Immunology and Allergy, Humanized, Immune Checkpoint Inhibitors, 6.2 Cellular and gene therapies, RC254-282, Cancer, Aged, 80 and over, Clinical/Translational Cancer Immunotherapy, Merkel cell carcinoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Progression-Free Survival, 6.1 Pharmaceuticals, 030220 oncology & carcinogenesis, Disease Progression, Molecular Medicine, Female, immunotherapy, medicine.medical_specialty, Clinical Trials and Supportive Activities, Immunology, Antibodies, Monoclonal, Humanized, Antibodies, 03 medical and health sciences, Clinical Research, Internal medicine, medicine, Humans, Neoplasm Staging, Aged, Salvage Therapy, Pharmacology, Chemotherapy, business.industry, Carcinoma, Evaluation of treatments and therapeutic interventions, Immunotherapy, medicine.disease, Carcinoma, Merkel Cell, 030104 developmental biology, Tumor progression, Merkel Cell, Skin cancer, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::272adca2addf0d58650483b69b745a95Test
https://doi.org/10.1136/jitc-2021-002478Test

المؤلفون: Elliot Chartash, Lokesh Jain, Dinesh P. de Alwis, Mallika Lala, Shu-Chih Su, Omobolaji Oyekunle Akala, Mizuho Kalabis, Vikram Sinha

المصدر: Cancer Research. 80:CT042-CT042

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, business.industry, Pembrolizumab, Clinical trial, 03 medical and health sciences, Regimen, 030104 developmental biology, 0302 clinical medicine, Pharmacokinetics, 030220 oncology & carcinogenesis, Internal medicine, Cohort, medicine, Every Three Weeks, media_common.cataloged_instance, Dosing, European union, business, media_common

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1d8ef5ccc60934dcfca3fe1cc81b3fcfTest
https://doi.org/10.1158/1538-7445.am2020-ct042Test

المؤلفون: Nicholas J. Petrelli, Michela Perego, Marilda Beqiri, Mizuho Kalabis, Denitsa Hristova, Rajasekharan Somasundaram, Min Xiao, Clemens Krepler, Meenhard Herlyn

المصدر: Clinical Cancer Research. 22:PR02-PR02

مصطلحات موضوعية: Genetically modified mouse, Cancer Research, biology, business.industry, Melanoma, medicine.disease, Immune checkpoint, Immune system, Oncology, Antigen, Immunology, Humanized mouse, biology.protein, Medicine, Antibody, business, Immunodeficient Mouse

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8d0506b5ced6fd89f03d0cb8c5ceeff4Test
https://doi.org/10.1158/1557-3265.pdx16-pr02Test